Toxicity assessment of nano-sized MAX phases: considerations for safe-by-design approaches

Jeong, Jaeseong; Bae, Su-Yong; Lee, Jinho; Kwon, Suh-young; Lee, Ju Han; Choi, Jinhee

doi:10.1039/d3en00528c

Cited by 1 publication

(2 citation statements)

References 77 publications

(143 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, no significant toxicity was observed in C. elegans and zebrafish embryos at the same concentration. 185 Maruthupandy et al examined the inflammatory potential of MXenes and graphene oxide through in vivo and in vitro tests. Pulmonary exposure in mice showed dose-dependent increases in toxicity end points.…”

Section: Healthcare Applicationsmentioning

confidence: 99%

“…At a concentration of 1 mg L –1 , MAX phases exhibited around 20% cytotoxicity and increased DNA strand breaks and IL-6 levels in BEAS-2B cells. However, no significant toxicity was observed in C. elegans and zebrafish embryos at the same concentration . Maruthupandy et al examined the inflammatory potential of MXenes and graphene oxide through in vivo and in vitro tests.…”

Section: Properties Of 2d Nanomaterials Used In Healthcare Applicationsmentioning

confidence: 99%

See 1 more Smart Citation

Recent Advances in Two-Dimensional Nanomaterials for Healthcare Monitoring

Manoharan,

Batcha,

Mahalingam

et al. 2024

ACS Sens.

View full text Add to dashboard Cite

The development of advanced technologies for the fabrication of functional nanomaterials, nanostructures, and devices has facilitated the development of biosensors for analyses. Two-dimensional (2D) nanomaterials, with unique hierarchical structures, a high surface area, and the ability to be functionalized for target detection at the surface, exhibit high potential for biosensing applications. The electronic properties, mechanical flexibility, and optical, electrochemical, and physical properties of 2D nanomaterials can be easily modulated, enabling the construction of biosensing platforms for the detection of various analytes with targeted recognition, sensitivity, and selectivity. This review provides an overview of the recent advances in 2D nanomaterials and nanostructures used for biosensor and wearable-sensor development for healthcare and healthmonitoring applications. Finally, the advantages of 2D-nanomaterial-based devices and several challenges in their optimal operation have been discussed to facilitate the development of smart highperformance biosensors in the future.

show abstract

Section: Healthcare Applicationsmentioning

confidence: 99%

Section: Properties Of 2d Nanomaterials Used In Healthcare Applicationsmentioning

confidence: 99%